8-KLeadership ChangesShareholder MattersExhibits & Filings

COCA COLA CO 8-K Report, Executive Changes (May 2, 2024)

Filed May 2, 2024For Securities:KO

Summary

The Coca-Cola Company filed an 8-K on May 1, 2024, reporting on the 2024 Annual Meeting of Shareowners held on May 1, 2024, and changes in its principal accounting officer. Key personnel changes include the appointment of Erin “Ellie” May as Chief Accounting Officer, effective June 1, 2024, taking over from Mark Randazza. Ms. May, who joined the company in 2023 after a significant tenure at Ernst & Young, will have a base salary of $470,000 and remain eligible for incentive programs. The most significant outcomes from the shareholder meeting involved the approval of key governance and compensation plans. Shareowners overwhelmingly approved The Coca-Cola Company 2024 Equity Plan, authorizing 240,000,000 shares for awards, and The Coca-Cola Company Global Employee Stock Purchase Plan. They also ratified the appointment of Ernst & Young LLP as the independent auditor. Conversely, shareowner proposals related to Diversity, Equity, and Inclusion reporting, Non-Sugar Sweeteners, and Medical Care risks were largely rejected, indicating shareowner alignment with current company strategies on these matters.

Key Highlights

  • 1Erin “Ellie” May appointed Chief Accounting Officer, effective June 1, 2024.
  • 2Mark Randazza transitions from Principal Accounting Officer to Senior Vice President and Assistant Controller.
  • 3Ms. May's new role includes a base salary of $470,000, with continued eligibility for incentive programs and adherence to share ownership guidelines.
  • 4Shareowners overwhelmingly approved The Coca-Cola Company 2024 Equity Plan, authorizing 240,000,000 shares for future equity awards.
  • 5The Coca-Cola Company Global Employee Stock Purchase Plan and the appointment of Ernst & Young LLP as independent auditors were also approved by shareowners.
  • 6Majority of shareowner proposals, including those on DEI reporting, non-sugar sweeteners, and medical care risks, were not approved by a significant margin.

Frequently Asked Questions